Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Bierman

Showing results (41-50 of 112) with videos related to

Pageof 12
Sort By:
Bone Marrow Transplantation|January 1, 1989
Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantationH C Schouten, J O Armitage, L W Klassen, et al.
Cancer|May 15, 1993
Prognostic significance of clinical and pathologic features in diffuse large B-cell lymphomaH Nakamine, R G Bagin, J M Vose, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1996
High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapyP J Bierman, J R Anderson, M B Freeman, et al.
Blood|November 15, 1989
Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformationH C Schouten, P J Bierman, W P Vaughan, et al.
Cancer Immunology, Immunotherapy : CII|December 1, 1996
Monocyte activation by an oral immunomodulator (bestatin) in lymphoma patients following autologous bone marrow transplantationK Ino, P J Bierman, M L Varney, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 1, 1996
Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disordersB N Smir, R J Hauke, P J Bierman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
The International Prognostic Factors Project score for advanced Hodgkin's disease is useful for predicting outcome of autologous hematopoietic stem cell transplantationP J Bierman, J C Lynch, R G Bociek, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 1, 1997
Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disordersB N Smir, R J Hauke, P J Bierman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1996
Hodgkin's disease following solid organ transplantationP J Bierman, J M Vose, A N Langnas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphomaJ M Vose, J R Anderson, A Kessinger, et al.
Pageof 12

Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
Bone Marrow Transplantation|January 1, 1989
Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantationH C Schouten, J O Armitage, L W Klassen, et al.
Cancer|May 15, 1993
Prognostic significance of clinical and pathologic features in diffuse large B-cell lymphomaH Nakamine, R G Bagin, J M Vose, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1996
High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapyP J Bierman, J R Anderson, M B Freeman, et al.
Blood|November 15, 1989
Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformationH C Schouten, P J Bierman, W P Vaughan, et al.
Cancer Immunology, Immunotherapy : CII|December 1, 1996
Monocyte activation by an oral immunomodulator (bestatin) in lymphoma patients following autologous bone marrow transplantationK Ino, P J Bierman, M L Varney, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 1, 1996
Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disordersB N Smir, R J Hauke, P J Bierman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
The International Prognostic Factors Project score for advanced Hodgkin's disease is useful for predicting outcome of autologous hematopoietic stem cell transplantationP J Bierman, J C Lynch, R G Bociek, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 1, 1997
Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disordersB N Smir, R J Hauke, P J Bierman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1996
Hodgkin's disease following solid organ transplantationP J Bierman, J M Vose, A N Langnas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphomaJ M Vose, J R Anderson, A Kessinger, et al.
Pageof 12